Delivery Order SPE2DX15D3020-SPE2DX24FPYUJ
Award Date
9/26/24
Potential Completion Date
9/27/24
Potential Value
$2.5K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,583.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,583.28 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGE, a specialty pharmaceutical product. The contract has a completion date of January 24, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,973.68 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of September 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,583.28, is for the delivery of COPAXONE 40 MG/ML syringes and is a Firm Fixed Price Delivery Order. The award does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these medical supplies to support the healthcare needs of the U.S. military and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,660.80 delivery order contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm-fixed price delivery order, with an ultimate completion date of June 9, 2025. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with an ID of SPE2DX15D1053 and SPE2DX24F6TAK, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, which is a delivery order, has a ceiling value of $18,256.91 and a firm fixed price pricing type. The contract is for the supply of COPAXONE 20 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through September 5, 2024. Amerisourcebergen, a for-profit...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE. The $1,055.54 delivery order, which does not have a set-aside designation, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a...
This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of COPAXONE 40 MG/ML 12S, a pharmaceutical product, to support defense and civilian healthcare providers. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which...
This federal contract award is a delivery order with a firm fixed price valued at $1,583.28 for COPAXONE 40 MG/ML SYRINGEML. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The funding agency is the Defense Logistics Agency (DLA) Troop Support Medical, which has awarded Amerisourcebergen Drug Corp numerous contracts to supply pharmaceuticals, medical supplies, and related distribution services to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,908.00 delivery order is for the supply of COPAXONE 40 MG/ML syringes, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...